Immunopharmacological profile of HWA 486, a novel isoxazol derivative. II: In vivo immunomodulating effects differ from those of cyclaphosphamide, prednisolone, or cyclosporin ABARTLETT, R. R.International journal of immunopharmacology. 1986, Vol 8, Num 2, pp 199-204, issn 0192-0561Article

Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity. I: Disease modifying action on adjuvant arthritis of the ratBARTLETT, R. R; SCHLEYERBACH, R.International journal of immunopharmacology. 1985, Vol 7, Num 1, pp 7-18, issn 0192-0561Article

Modulation of immunoglobulin dysregulation in graft versus host-and systemic lupus erythematosus-like diseases by malononitrilamidesSCHORLEMMER, H. U; BARTLETT, R. R.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4153-4155, issn 0041-1345Conference Paper

Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimusSCHORLEMMER, H. U; BARTLETT, R. R; LINDNER, J. K et al.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4099-4103, issn 0041-1345Conference Paper

Leflunomide prevents the development of experimentally induced myasthenia gravisVIDIC-DANKOVIC, B; KOSEC, D; DAMJANOVIC, M et al.International journal of immunopharmacology. 1995, Vol 17, Num 4, pp 273-281, issn 0192-0561Article

Effects of leflunomide on immune responses and models of inflammationBARTLETT, R. R; ANAGNOSTOPULOS, H; ZIELINSKI, T et al.Springer seminars in immunopathology. 1993, Vol 14, Num 4, pp 381-394, issn 0344-4325Article

Synthesis of basic substituted pyridines: a new class of antiasthmatic-antiallergic agentsANAGNOSTOPOULOS, H; BARTLETT, R. R; ELBEN, U et al.European journal of medicinal chemistry. 1989, Vol 24, Num 3, pp 227-232, issn 0223-5234Article

Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomideJARMAN, E. R; KUBA, A; MONTERMANN, E et al.Clinical and experimental immunology (Print). 1999, Vol 115, Num 2, pp 221-228, issn 0009-9104Article

The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodentsSCHORLEMMER, H. U; KURRLE, R; BARTLETT, R. R et al.Drugs under experimental and clinical research. 1997, Vol 23, Num 5-6, pp 167-173, issn 0378-6501Article

Malononitrilamides inhibit the development of various murine graft-vs-host diseasesSCHORLEMMER, H. U; KURRLE, R; BARTLETT, R. R et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3043-3047, issn 0041-1345Conference Paper

Leflunomide therapy following penetrating keratoplasty in the ratCOUPLAND, S. E; KLEBE, S; KAROW, A.-C et al.Graefe's archive for clinical and experimental ophthalmology. 1994, Vol 232, Num 10, pp 622-627, issn 0721-832XArticle

Immunomodulation of proteoglycan-induced progressive polyarthritis by leflunomideGLANT, T. T; MIKECZ, K; BARTLETT, R. R et al.Immunopharmacology (New York). 1992, Vol 23, Num 2, pp 105-116, issn 0162-3109Article

Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host diseaseSCHORLEMMER, H. U; BARTLETT, R. R; KURRLE, R et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 1298-1301, issn 0041-1345Conference Paper

Effects of leflunomide (HWA 486) on expression of lymphocyte activation markersZIELINSKI, T; MÜLLER, H.-J; BARTLETT, R. R et al.Collection sécurité. 1993, Vol 38, pp C80-C82, issn 0538-4818, NSConference Paper

Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritisSCHORLEMMER, H. U; BARTLETT, R. R; SCHLEYERBACH, R et al.Drugs under experimental and clinical research. 1991, Vol 17, Num 10-11, pp 471-484, issn 0378-6501Article

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionBARTLETT, R. R; DIMITRIJEVIC, M; FINNEGAN, A et al.Agents and actions. 1991, Vol 32, Num 1-2, pp 10-21, issn 0065-4299, 12 p.Conference Paper

Cefodizime, an aminothiazolyl cephalosporin. IV: Influence on the immune systemLIMBERT, M; BARTLETT, R. R; DICKNEITE, G et al.Journal of antibiotics (Tokyo. 1968). 1984, Vol 37, Num 12, pp 1719-1726, issn 0021-8820Article

Effects of the immunosuppressive malononitrilamides on rheumatoid and systemic lupus erythematosus (SLE)-like diseasesSCHORLEMMER, H. U; BARTLETT, R. R.International journal of immunotherapy. 1997, Vol 13, Num 1-2, pp 1-7, issn 0255-9625Article

Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE)SCHORLEMMER, H. U; BARTLETT, R. R.Drugs under experimental and clinical research. 1997, Vol 23, Num 5-6, pp 175-181, issn 0378-6501Article

A novel immunomodulating agent-leflunomide inhibits experimental autoimmune diabetes in miceSTOSIC-GRUJICIC, S; DIMITRIJEVIC, M; BARTLETT, R. R et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3072-3073, issn 0041-1345Conference Paper

Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of mononuclear cells in rheumatoid arthritisDIMITRIJEVIC, M; BARTLETT, R. R.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3086-3087, issn 0041-1345Conference Paper

Differential modulation of the effects of lipopolysaccharide on macrophages by a major outer membrane protein of Proteus mirabilisWEBER, G; LINK, F; FERBER, E et al.The Journal of immunology (1950). 1993, Vol 151, Num 1, pp 415-424, issn 0022-1767Article

Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivativeSCHORLEMMER, H. U; SEILER, F. R; BARTLETT, R. R et al.Transplantation proceedings. 1993, Vol 25, Num 1, pp 763-767, issn 0041-1345, 1Conference Paper

Curative effects of 15-deoxyspergualin on murine systemic lupus erythematosus-like disease in MRL/1 autoimmune miceSCHORLEMMER, H. U; BARTLETT, R. R; SEILER, F. R et al.International journal of immunotherapy. 1991, Vol 7, Num 4, pp 169-180, issn 0255-9625Article

Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat modelSCHORLEMMER, H. U; BARTLETT, R. R; KURRLE, R et al.Transplantation proceedings. 1999, Vol 31, Num 1-2, pp 851-853, issn 0041-1345Conference Paper